Myocardial Recovery in Peripartum Cardiomyopathy After Hyperprolactinemia Treatment on BIVAD.

ASAIO J

From the *Department for Cardiac Surgery, Medical University of Vienna, Wien, Austria; †Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Wien, Austria; ‡Department for Cardiovascular Anaesthesia, Medical University of Vienna, Wien, Austria; and §Ludwig-Boltzmann-Cluster for Cardiovascular Research, Vienna, Austria.

Published: October 2017

Peripartum cardiomyopathy (PPCMP) requiring mechanical circulatory support is rare; however, it is a life-threatening disease with recovery rates poorer than expected. Herein, we describe a case of successful recovery of a patient with PPCMP. Implantation of a biventricular ventricular assist device was performed; additionally, the patient's hyperprolactinemia was treated with cabergoline, resulting in a fast complete restoration of ventricular function.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0000000000000452DOI Listing

Publication Analysis

Top Keywords

peripartum cardiomyopathy
8
myocardial recovery
4
recovery peripartum
4
cardiomyopathy hyperprolactinemia
4
hyperprolactinemia treatment
4
treatment bivad
4
bivad peripartum
4
cardiomyopathy ppcmp
4
ppcmp requiring
4
requiring mechanical
4

Similar Publications

Peripartum cardiomyopathy (PPCM) and takotsubo cardiomyopathy (TCM) are cardiac conditions that can occur in the peripartum period. They have distinct characteristics and incidence rates; although rare, both contribute to the second leading cause of all-cause maternal mortality in the state of Missouri. PPCM can lead to heart failure, and TCM can cause acute arrhythmias leading to sudden cardiac death in otherwise healthy individuals.

View Article and Find Full Text PDF

Introduction: Peripartum cardiomyopathy (PPCM) is a pregnancy related cardiomyopathy with a high potential for recovery. One of the contemporary predictors studied in cardiomyopathy is right ventricular (RV) function during initial presentation.

Purpose: This study aimed to determine the role of RV systolic function based on the various RV function parameters by two-dimensional transthoracic echocardiography (2DE) to predict PPCM recovery within 6 months of follow-up and identify the most accurate parameter among them.

View Article and Find Full Text PDF

Peripartum cardiomyopathy management: insights from a Latin American case report.

Arch Peru Cardiol Cir Cardiovasc

December 2024

Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru. Universidad San Ignacio de Loyola Vicerrectorado de Investigación Universidad San Ignacio de Loyola Lima Peru.

Peripartum cardiomyopathy (PPCM) is a potentially life-threatening condition that can occur during the late pregnancy or puerperium. A 31-year-old woman with a recent twin pregnancy presented with heart failure symptoms nine days postpartum. On admission, she had volume overload and hemodynamic compromise, which was rapidly reversed with inotropic levosimendan support.

View Article and Find Full Text PDF

Background: Cardiovascular diseases are the primary cause of nonobstetric morbidity and mortality in pregnant women worldwide. Pakistan's high maternal and neonatal mortality rates underscore the need for effective screening protocols to detect cardiovascular diseases during pregnancy.

Objectives: The objective of this study was to assess the prevalence and factors associated with structural heart disease among pregnant women without active cardiorespiratory symptoms (no symptoms or symptoms attributed to pregnancy) attending routine antenatal appointments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!